Total planned funding: $393,507,326
Clear active filters
FHI 360
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Zambia | $73,014,046 |
Mozambique | $61,694,003 |
Nigeria | $58,945,068 |
Kenya | $21,213,687 |
Tanzania | $19,949,842 |
Burundi | $18,190,879 |
South Africa | $16,285,334 |
Vietnam | $15,759,049 |
Haiti | $12,098,143 |
Indonesia | $10,694,829 |
India | $9,460,871 |
South Sudan | $8,573,029 |
Ghana | $8,272,500 |
Rwanda | $8,180,675 |
Côte d'Ivoire | $7,818,896 |
Zimbabwe | $5,558,697 |
Cambodia | $4,700,000 |
Asia Regional Program | $3,727,521 |
Papua New Guinea | $3,708,980 |
Botswana | $3,620,000 |
Ethiopia | $2,885,333 |
Malawi | $2,735,759 |
Caribbean Region | $2,519,565 |
Central America Region | $2,283,457 |
Angola | $2,222,878 |
Uganda | $2,002,161 |
Democratic Republic of the Congo | $1,801,200 |
Namibia | $1,497,275 |
Dominican Republic | $1,418,747 |
Eswatini | $914,902 |
China | $850,000 |
Cameroon | $360,000 |
Central Asia Region | $350,000 |
Thailand | $200,000 |
Organizational Types
NGO | $385,855,889 |
Implementing Agency | $7,651,437 |
Program Areas
Care | $113,602,841 |
Prevention | $108,757,212 |
Treatment | $87,568,872 |
Testing | $42,714,730 |
Governance and Systems | $40,863,671 |
Budget Codes
HTXS: Treatment: Adult Treatment | $77,484,671 |
HVOP: Sexual Prevention: Other Sexual Prevention | $56,562,972 |
HKID: Care: Orphans and Vulnerable Children | $48,213,888 |
HBHC: Care: Adult Care and Support | $46,098,693 |
HVCT: Testing: HIV Testing and Counseling | $42,714,730 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $28,676,742 |
HVSI: Strategic Information | $15,321,059 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $13,751,109 |
HLAB: Laboratory Infrastructure | $13,502,112 |
HVTB: Care: TB/HIV | $12,129,359 |
OHSS: Health Systems Strengthening | $12,040,500 |
PDTX: Treatment: Pediatric Treatment | $10,084,201 |
PDCS: Care: Pediatric Care and Support | $7,160,901 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $6,144,048 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $3,085,841 |
HMIN: Biomedical Prevention: Injection Safety | $360,100 |
HMBL: Biomedical Prevention: Blood Safety | $176,400 |
HTXD: Treatment: ARV Drugs | $0 |
Top Partner Programs
FHI 360:
$393,507,326
View countries